{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:40:45Z","timestamp":1793904045441,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1DA049394"],"award-info":[{"award-number":["UM1DA049394"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1DA049415"],"award-info":[{"award-number":["UM1DA049415"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1DA049417"],"award-info":[{"award-number":["UM1DA049417"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1DA049406"],"award-info":[{"award-number":["UM1DA049406"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1DA049412"],"award-info":[{"award-number":["UM1DA049412"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCT04111939"],"award-info":[{"award-number":["NCT04111939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Pro00038088"],"award-info":[{"award-number":["Pro00038088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.josat.2023.209077","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T21:27:59Z","timestamp":1684531679000},"page":"209077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky"],"prefix":"10.1016","volume":"150","author":[{"given":"Shikhar","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan R.","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeeta","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Pustz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric","family":"Bayly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209077_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsat.2018.01.006","article-title":"Employment after beginning treatment for substance use disorders: The impact of race\/ethnicity and client community of residence","volume":"87","author":"Acevedo","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209077_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108321","article-title":"Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time","volume":"216","author":"Althoff","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209077_bb0015","doi-asserted-by":"crossref","first-page":"Cd003409","DOI":"10.1002\/14651858.CD003409.pub4","article-title":"Methadone at tapered doses for the management of opioid withdrawal","volume":"2013","author":"Amato","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.josat.2023.209077_bb0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: A US Nationwide small area analysis","volume":"24","author":"Amiri","year":"2021","journal-title":"Value in Health"},{"key":"10.1016\/j.josat.2023.209077_bb0025","series-title":"New tools for spatial data analysis: Proceedings of the specialist meeting","article-title":"Visualizing multivariate spatial correlation with dynamically linked windows","author":"Anselin","year":"2002"},{"issue":"4","key":"10.1016\/j.josat.2023.209077_bb0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0740-5472(03)00188-0","article-title":"Distance traveled to outpatient drug treatment and client retention","volume":"25","author":"Beardsley","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"8","key":"10.1016\/j.josat.2023.209077_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18084246","article-title":"Facility attractiveness and social vulnerability impacts on spatial accessibility to opioid treatment programs in South Carolina","volume":"18","author":"Bozorgi","year":"2021","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.josat.2023.209077_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsat.2019.03.013","article-title":"Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire","volume":"101","author":"Cao","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209077_bb0045","author":"Centers for Disease Control and Prevention"},{"issue":"3\u20134","key":"10.1016\/j.josat.2023.209077_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/09595237400185281","article-title":"Evaluating the friction of distance parameter in gravity models","volume":"8","author":"Cliff","year":"1974","journal-title":"Regional Studies"},{"key":"10.1016\/j.josat.2023.209077_bb0055","author":"Cross"},{"key":"10.1016\/j.josat.2023.209077_bb0060","article-title":"Racial\/ethnic residential segregation and the availability of opioid and substance use treatment facilities in US counties, 2009-2019","volume":"20","author":"DiNardi","year":"2022","journal-title":"SSM Popul Health"},{"issue":"15","key":"10.1016\/j.josat.2023.209077_bb0065","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain-United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.josat.2023.209077_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.11.001","article-title":"People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky","volume":"85","author":"Fadanelli","year":"2020","journal-title":"The International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.josat.2023.209077_bb0075","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsat.2013.10.005","article-title":"Criminal justice outcomes after engagement in outpatient substance abuse treatment","volume":"46","author":"Garnick","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209077_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102906","article-title":"US drug overdose mortality: 2009-2018 increases affect young people who use drugs","volume":"85","author":"Gaur","year":"2020","journal-title":"The International Journal on Drug Policy"},{"issue":"4","key":"10.1016\/j.josat.2023.209077_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.josat.2023.209077_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5206\/uwomj.v86i2.2015","article-title":"Why can\u2019t patients last the wait?","volume":"86","author":"Guitar","year":"2017","journal-title":"University of Western Ontario Medical Journal"},{"issue":"6 Suppl 3","key":"10.1016\/j.josat.2023.209077_bb0095","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","article-title":"Policy pathways to address provider workforce barriers to buprenorphine treatment","volume":"54","author":"Haffajee","year":"2018","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2023.209077_bb0100","article-title":"The HEALing (helping to end addiction long-term (SM)) communities study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices","volume":"217","author":"HEALing Communities Study Consortium","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209077_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13011-016-0085-y","article-title":"Systemic and individual factors in the buprenorphine treatment-seeking process: A qualitative study","volume":"12","author":"Hewell","year":"2017","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"2","key":"10.1016\/j.josat.2023.209077_bb0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0033354920968806","article-title":"Differences in opioid overdose mortality rates among middle-aged adults by race\/ethnicity and sex, 1999-2018","volume":"136","author":"Hoopsick","year":"2021","journal-title":"Public Health Reports"},{"issue":"2","key":"10.1016\/j.josat.2023.209077_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Annals of Family Medicine"},{"issue":"9","key":"10.1016\/j.josat.2023.209077_bb0120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2023.209077_bb0125","author":"Langford"},{"issue":"3","key":"10.1016\/j.josat.2023.209077_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1016\/j.josat.2023.209077_bb0135","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2105\/AJPH.2021.306431","article-title":"Disparities in opioid overdose death trends by race\/ethnicity, 2018-2019, from the HEALing communities study","volume":"111","author":"Larochelle","year":"2021","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.josat.2023.209077_bb0140","first-page":"41","article-title":"Identification and description of non-fatal opioid overdoses using Rhode Island EMS data, 2016-2018","volume":"102","author":"Lasher","year":"2019","journal-title":"R I Med J (2013)"},{"issue":"43","key":"10.1016\/j.josat.2023.209077_bb0145","doi-asserted-by":"crossref","first-page":"967","DOI":"10.15585\/mmwr.mm6843a3","article-title":"Racial\/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged \u226518 years in metropolitan areas - United States, 2015-2017","volume":"68","author":"Lippold","year":"2019","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.josat.2023.209077_bb0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","article-title":"A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States","volume":"46","author":"Lister","year":"2020","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"S2","key":"10.1016\/j.josat.2023.209077_bb0155","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.2105\/AJPH.2022.306767","article-title":"Understanding racial inequities in the implementation of harm reduction initiatives","volume":"112","author":"Lopez","year":"2022","journal-title":"American Journal of Public Health"},{"issue":"4","key":"10.1016\/j.josat.2023.209077_bb0160","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.healthplace.2009.06.002","article-title":"An enhanced two-step floating catchment area (E2SFCA) method for measuring spatial accessibility to primary care physicians","volume":"15","author":"Luo","year":"2009","journal-title":"Health & Place"},{"issue":"6","key":"10.1016\/j.josat.2023.209077_bb0165","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1068\/b29120","article-title":"Measures of spatial accessibility to health care in a GIS environment: Synthesis and a case study in the Chicago region","volume":"30","author":"Luo","year":"2003","journal-title":"Environment and Planning. B, Planning & Design"},{"issue":"1","key":"10.1016\/j.josat.2023.209077_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jrh.12300","article-title":"Trends and patterns of opioid analgesic prescribing: Regional and rural-urban variations in Kentucky from 2012 to 2015","volume":"35","author":"Luu","year":"2019","journal-title":"The Journal of Rural Health"},{"key":"10.1016\/j.josat.2023.209077_bb0175","first-page":"Cd002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2023.209077_bb0180","series-title":"Understanding declining rates of drug overdose mortality in eastern Kentucky","author":"Meit","year":"2020"},{"issue":"3","key":"10.1016\/j.josat.2023.209077_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jsat.2013.09.003","article-title":"Determinants of buprenorphine treatment for opioid dependence","volume":"46","author":"Murphy","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209077_bb0190","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, E., & Medicine","year":"2019"},{"key":"10.1016\/j.josat.2023.209077_bb0195","author":"National Center for Health Statistics"},{"key":"10.1016\/j.josat.2023.209077_bb0200","author":"Ohio Task Force Commanders Association"},{"issue":"4","key":"10.1016\/j.josat.2023.209077_bb0205","doi-asserted-by":"crossref","first-page":"588","DOI":"10.15288\/jsad.2017.78.588","article-title":"Association between process-based quality indicators and mortality for patients with substance use disorders","volume":"78","author":"Paddock","year":"2017","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"2","key":"10.1016\/j.josat.2023.209077_bb0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005650-198102000-00001","article-title":"The concept of access: Definition and relationship to consumer satisfaction","volume":"19","author":"Penchansky","year":"1981","journal-title":"Medical Care"},{"issue":"4","key":"10.1016\/j.josat.2023.209077_bb0215","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/002204260603600404","article-title":"Waiting time as a barrier to treatment entry: Perceptions of substance users","volume":"36","author":"Redko","year":"2006","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.josat.2023.209077_bb0220","author":"Rhode Island Department of Health"},{"issue":"1_suppl","key":"10.1016\/j.josat.2023.209077_bb0225","doi-asserted-by":"crossref","first-page":"72s","DOI":"10.1177\/00333549211018673","article-title":"Emergency medical services and syndromic surveillance: A comparison with traditional surveillance and effects on timeliness","volume":"136","author":"Rock","year":"2021","journal-title":"Public Health Reports"},{"key":"10.1016\/j.josat.2023.209077_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108011","article-title":"Appointment wait-times and arrival for patients at a low-barrier access addiction clinic","volume":"114","author":"Roy","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209077_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2021.101538","article-title":"Characterizing opioid-involved overdose risk in local communities: An opioid overdose vulnerability assessment across Indiana, 2017","volume":"24","author":"Sawyer","year":"2021","journal-title":"Preventive Medical Reports"},{"issue":"6","key":"10.1016\/j.josat.2023.209077_bb0240","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0306-4603(02)00218-6","article-title":"The influence of distance on utilization of outpatient mental health aftercare following inpatient substance abuse treatment","volume":"28","author":"Schmitt","year":"2003","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2023.209077_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108710","article-title":"Growing racial\/ethnic disparities in buprenorphine distribution in the United States, 2007-2017","volume":"223","author":"Schuler","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209077_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108328","article-title":"Operationalizing and selecting outcome measures for the HEALing communities study","volume":"217","author":"Slavova","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209077_bb0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/add.15163","article-title":"Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States","volume":"116","author":"Smart","year":"2021","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.josat.2023.209077_bb0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08897077.2018.1449166","article-title":"A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees","volume":"39","author":"Stein","year":"2018","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209077_bb0270","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2017.10.002","article-title":"Prescribing patterns of buprenorphine waivered physicians","volume":"181","author":"Thomas","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209077_bb0275","author":"U.S. Census Bureau"},{"key":"10.1016\/j.josat.2023.209077_bb0280","author":"US Department of Health & Human Services"},{"issue":"2","key":"10.1016\/j.josat.2023.209077_bb0285","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.healthplace.2004.02.003","article-title":"Assessing spatial and nonspatial factors for healthcare access: Towards an integrated approach to defining health professional shortage areas","volume":"11","author":"Wang","year":"2005","journal-title":"Health & Place"},{"key":"10.1016\/j.josat.2023.209077_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108325","article-title":"The opioid-overdose reduction continuum of care approach (ORCCA): Evidence-based practices in the HEALing communities study","volume":"217","author":"Winhusen","year":"2020","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:11:24Z","timestamp":1778937084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923001285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":57,"alternative-id":["S2949875923001285"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209077","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209077"}}